Home Cart Sign in  
Chemical Structure| 913822-46-5 Chemical Structure| 913822-46-5

Structure of SC75741
CAS No.: 913822-46-5

Chemical Structure| 913822-46-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SC75741 is a novel NF-kappaB inhibitor.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SC75741

CAS No. :913822-46-5
Formula : C29H23N7O2S2
M.W : 565.67
SMILES Code : O=C(C1=CSC(C2CCN(C3=C4C(C=CS4)=NC=N3)CC2)=N1)NC5=NC6=CC=C(C(C7=CC=CC=C7)=O)C=C6N5
MDL No. :MFCD18206785
InChI Key :QNZVBFMXWNWVKG-UHFFFAOYSA-N
Pubchem ID :23661638

Safety of SC75741

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of SC75741

pyroptosis

Isoform Comparison

Biological Activity

Target
  • NF-κB

    NF-κB, EC50:200 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293WT cells 5 µM 6-12 hours SC75741 enhanced autophagy activity Front Pharmacol. 2021 Oct 29;12:741219
LLC-PK cells 20 µM 24 hours SC75741 inhibited PDCoV infection Int J Mol Sci. 2022 Mar 18;23(6):3280
SH-SY5YGT25 cells 5 µM 24 hours SC75741 promoted TDP25 degradation Front Pharmacol. 2021 Oct 29;12:741219
H4GT25 cells 5 µM 24 hours SC75741 significantly reduced TDP25 protein levels Front Pharmacol. 2021 Oct 29;12:741219
OCCM-30 cells 5 µM 2 hours Inhibited the NF-κB pathway, reduced NLRP3 expression and pyroptosis in P. gingivalis-infected OCCM-30 cells Heliyon. 2024 May 7;10(9):e30814
Duck primary monocytes/macrophages 1 µMol/mL 24 hours Evaluate the antiviral activity of SC75741 in duck monocytes/macrophages. Results showed that SC75741 significantly inhibited DPV replication. Poult Sci. 2021 May;100(5):101085
Duck primary astrocytes 5 µMol/mL 24 hours Evaluate the antiviral activity of SC75741 in duck astrocytes. Results showed that SC75741 significantly inhibited VSV-GFP and DTMUV replication but had no effect on DPV. Poult Sci. 2021 May;100(5):101085
Duck primary neurons 5 µMol/mL 24 hours Evaluate the antiviral activity of SC75741 in duck neurons. Results showed that SC75741 significantly inhibited VSV-GFP and DTMUV replication. Poult Sci. 2021 May;100(5):101085
T24 cells 5 µM 24 hours Inhibition of NF-κB signaling pathway, reducing clonogenic survival and invasion capability of bladder cancer cells. J Clin Med. 2019 Nov 13;8(11):1954
MB49 cells 5 µM 24 hours Inhibition of NF-κB signaling pathway, reducing clonogenic survival and invasion capability of bladder cancer cells. J Clin Med. 2019 Nov 13;8(11):1954
Duck embryo fibroblast cells (DEF) 0.2–50 µMol/mL 24, 48, or 72 hours Evaluate the antiviral activity of SC75741 against VSV-GFP, DTMUV, and DPV-GFP. Results showed that SC75741 significantly inhibited viral replication in a dose-dependent manner. Poult Sci. 2021 May;100(5):101085
SW982 cells 2 µM 48 hours Inhibited the expression of NF-κB and α-SMA, reduced levels of inflammatory markers TNF-α and IL-6 Int J Mol Sci. 2021 Oct 14;22(20):11082
Human nucleus pulposus cells 5 µM 6 and 12 hours To investigate the inhibitory effect of SC75741 on the NF-κB signaling pathway, results showed that SC75741 reversed rhS100A9-induced NP cell apoptosis, matrix degradation, and inflammatory response. J Cell Mol Med. 2021 May;25(10):4709-4720
RAW264.7 cells 2 µM Overnight Reduced the population of TRAP+ multinucleated cells and downregulated MMP9, RANKL, TRAP, and OPG proteins Int J Mol Sci. 2021 Oct 14;22(20):11082

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Wistar rats Papain-induced osteoarthritis model Oral 15 mg/kg Three times a week for 12 weeks Ameliorated articular cartilage destruction, reduced OARSI scores, suppressed inflammatory markers NF-κB, TNF-α, IL-6, and miR-21, and promoted chondrogenesis inducers GDF-5, SOX5, TGF-β1, BMPR2, and COL4A1 Int J Mol Sci. 2021 Oct 14;22(20):11082
Nude mice (BALB/c-nu) U251 cell xenograft tumor model Intraperitoneal injection 5 mg/kg Once daily for 3 weeks Inhibit NF-κB activity and reverse RIP2 overexpression-induced TMZ resistance CNS Neurosci Ther. 2022 Dec;28(12):2319-2330.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.77mL

0.35mL

0.18mL

8.84mL

1.77mL

0.88mL

17.68mL

3.54mL

1.77mL

References

 

Historical Records

Categories